Compare ANIP & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | SHO |
|---|---|---|
| Founded | 2001 | 1995 |
| Country | United States | United States |
| Employees | N/A | 37 |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 1999 | N/A |
| Metric | ANIP | SHO |
|---|---|---|
| Price | $80.75 | $11.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $110.00 | $9.79 |
| AVG Volume (30 Days) | 300.1K | ★ 3.3M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $206,547,000.00 | N/A |
| Revenue This Year | $21.01 | $3.95 |
| Revenue Next Year | $17.59 | $2.30 |
| P/E Ratio | ★ $63.55 | $966.33 |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $62.61 | $8.52 |
| 52 Week High | $99.50 | $12.07 |
| Indicator | ANIP | SHO |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 51.60 |
| Support Level | $77.16 | $8.81 |
| Resistance Level | $83.66 | $12.07 |
| Average True Range (ATR) | 2.55 | 0.26 |
| MACD | -0.44 | -0.07 |
| Stochastic Oscillator | 10.29 | 38.71 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.